Diab Mfrej Almhana MD

Psychiatry•Avon Lake, OH

Child & Adolescent Psychiatry

Physician

Join to View Full Profile

223 Miller RdAvon Lake, OH 44012
Phone+1 440-930-2002
Fax+1 440-930-2085

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Child and Adolescent Psychiatry, 2000 - 2001
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Psychiatry, 1997 - 2000
Damascus University Faculty of MedicineClass of 1994

Certifications & Licensure

OH State Medical License 1999 - 2027
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Bipolar Study in Adults at Least 18 Years of Age Start of enrollment: 2003 Aug 01
Completed
Phase 4
Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder Start of enrollment: 2005 Dec 01
Completed
Phase 3
Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients. Start of enrollment: 2006 Mar 01
Completed
Phase 3
Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders Start of enrollment: 2006 Apr 01
Completed
Phase 3
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder Start of enrollment: 2006 Sep 01
Completed
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
ACTIVE_NOT_RECRUITING
PHASE3
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression Start of enrollment: 2009 Apr 01
Completed
Phase 3
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder Start of enrollment: 2010 Jun 01
Completed
Phase 3
Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder Start of enrollment: 2010 Aug 01
Completed
Phase 3
Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder Start of enrollment: 2011 Jan 01
Terminated
Phase 2
Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384) Start of enrollment: 2011 Dec 01
Completed
Phase 3
Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Start of enrollment: 2011 Oct 19
Completed
Phase 3
Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Start of enrollment: 2011 Jul 27
Completed
Phase 3
Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder Start of enrollment: 2012 Apr 01
Completed
Phase 2
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Start of enrollment: 2012 Sep 01
Completed
Phase 2
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Start of enrollment: 2012 Oct 01
Terminated
Phase 2
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Start of enrollment: 2012 Jun 01
Completed
Phase 2
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder Start of enrollment: 2012 Aug 01
Terminated
Phase 3
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Start of enrollment: 2013 Jan 01
Completed
Phase 3
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder Start of enrollment: 2013 Jul 11
Completed
Phase 3
Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) Start of enrollment: 2015 Feb 28
Completed
Phase 3
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder Start of enrollment: 2015 May 02
Completed
Phase 3
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Start of enrollment: 2019 Oct 04
Completed
Phase 2
A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder Start of enrollment: 2019 Oct 17
COMPLETED
PHASE2
Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents Start of enrollment: 2019 Jun 28
Completed
Phase 2
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. Start of enrollment: 2021 Apr 28
RECRUITING
PHASE3
A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder Start of enrollment: 2019 May 30
Completed
Phase 4
Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone Start of enrollment: 2018 Nov 09
Completed
Phase 3
The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone Start of enrollment: 2018 Nov 10
Completed
Phase 3
Real-life Effectiveness of Vortioxetine in Depression Start of enrollment: 2017 Nov 17
Completed
Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder Start of enrollment: 2018 Oct 13
Terminated
Phase 4
Join now to see all